The European Union’s health regulator on Friday rejected Eli Lilly’s (LLY) Alzheimer’s drug, Kisunla, citing risks of brain swelling and bleeding. It’s a major setback for the company as it co [...]
Mark Zuckerberg took the stand Wednesday in a high-profile jury trial over social media addiction. In an appearance that was described by NBC News as "combative," the Facebook founder report [...]
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]